证券代码：600866 证券简称：星湖科技 公告编号：临 2025-024 广东肇庆星湖生物科技股份有限公司 关于前期诉讼进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： 一、本次诉讼的基本情况 公 司 于 2024 年 2 月 29 日 在 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）披露了《关于子公司涉及诉讼的公告》（公告编 号：临 2024-001）。原告 CJ 第一制糖株式会社认为公司全资子公司 肇东星湖生物科技有限公司（以下简称"被告"）侵害其发明专利， 向黑龙江省哈尔滨市中级人民法院提起诉讼，原告请求如下： 案件所处的诉讼阶段：原告撤诉。 上市公司所处的当事人地位：公司全资子公司肇东星湖生物 科技有限公司为被告。 涉案的金额：人民币 2,000 万元及诉讼费用。 对上市公司损益的影响：原告 CJ 第一制糖株式会社撤诉，不 会对公司及子公司本期利润或期后利润产生重大影响。 1.判令被告立即停止生产、销售、许诺销售侵犯原告第 200910266085.7号发明专利权的 ...

2024 年年度股东大会会议资料 广东肇庆星湖生物科技股份有限公司 2024 年年度股东大会会议资料 2025 年 6 月 6 日 2024 年年度股东大会会议资料 2024 年年度股东大会会议资料 会议须知 为确保各位股东和股东代表依法行使股东权利，保证股东大会的 正常秩序和议事效率，请遵守以下会议须知： 一、股东及股东代表参加本次股东大会，依法享有发言权、质询 权、表决权等各项权利，应遵守本次大会议事规则，认真履行法定义 务，不得侵犯其他股东的权益，不得扰乱大会的正常秩序。 二、如股东拟在本次股东大会上发言，请提前准备发言意向及要 点，并注明所需要的时间。特别提示：因股东大会时间有限，股东发 言由公司按登记情况统筹安排，公司不能保证所有填写发言意向及要 点的股东均能在本次股东大会上发言。 三、股东发言主题应与本次股东大会表决事项有关，与本次股东 大会议题无关或将泄露公司商业秘密或可能损害公司、股东共同利益 的质询，大会主持人或其指定的有关人员有权拒绝回答。 四、本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式。公司通过上海证券交易所网络投票系统向公司股东提供网 络形式的投票平台，股东可以在网 ...

Group 1 - The sugar substitute concept is experiencing a decline in the afternoon trading session, with Baolingbao (002286) nearing a trading halt [1] - Other companies in the sector, including Sanyuan Bio (301206), Jinhai Bio (002688), Vinegar Chemical (603968), and Xinghuo Technology (600866), are also seeing a drop in stock prices [1] - There is an influx of dark pool funds entering these stocks, indicating potential interest from institutional investors [1]

证券代码：600866 证券简称：星湖科技 公告编号：临 2025-023 广东肇庆星湖生物科技股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东大会类型和届次 2024年年度股东大会 (二)股东大会召集人：董事会 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 6 日 10 点 00 分 召开地点：广东省肇庆市端州区工农北路 67 号公司会议室 股东大会召开日期：2025年6月6日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 6 日 至2025 年 6 月 6 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联 ...

Group 1 - The sugar substitute concept declined by 0.82%, ranking among the top declines in the concept sector, with companies like Baolingbao, Bailong Chuangyuan, and Chenguang Biotech experiencing significant drops [1][2] - Among the sugar substitute stocks, 8 saw price increases, with Zhonghua International, Luxin Investment, and Xinghu Technology rising by 1.37%, 1.34%, and 1.09% respectively [1][2] - The sugar substitute sector experienced a net outflow of 118 million yuan, with 17 stocks seeing net outflows, and 5 stocks with outflows exceeding 10 million yuan, led by Jinhai Biological with a net outflow of 44.98 million yuan [2][3] Group 2 - The top net inflow stocks in the sugar substitute sector included Jinhai Industrial, Rhine Biological, and Shengquan Group, with net inflows of 16.36 million yuan, 12.29 million yuan, and 5.05 million yuan respectively [2][3] - The outflow leaderboard for the sugar substitute sector featured Jinhai Biological, Yasheng Group, and Baolingbao, with respective outflows of 44.98 million yuan, 25.20 million yuan, and 22.92 million yuan [2][3] - The trading activity in the sugar substitute sector showed varied turnover rates, with Baolingbao at 14.36% and Jinhai Biological at 6.48% [2][3]

Investment Rating - The report maintains an "Overweight" rating for the basic chemicals and oil and gas sectors [4]. Core Viewpoints - The overall price spread in the industry improved in April 2025, with downstream sectors expected to recover first due to cost reduction and demand improvement [1][8]. - The April PMI data indicates a slight contraction in the chemical raw materials and products industry, suggesting ongoing supply-demand mismatches [1][11]. - The report anticipates a recovery starting in the second half of 2025, driven by improved domestic demand and exports to Asia, Africa, and Latin America [1][11]. Summary by Sections Supply and Demand Dynamics - The price spread for downstream chemical products improved in April due to supply constraints and seasonal demand replenishment, while midstream products still await recovery [2][8]. - The April PMI data was reported at 49, indicating a contraction in the chemical sector, but a recovery is expected as domestic economic conditions improve [11][24]. Investment Strategy - The report suggests that the second half of 2025 may mark the beginning of an upward trend, with a focus on resilient internal and external demand and improved competitive landscapes [3][32]. - Recommended stocks include China Petroleum, Hengli Petrochemical, and Juhua Co., with a focus on companies with strong dividend yields and cost reduction capabilities [6][32]. Key Recommendations - The report highlights specific companies for investment based on their competitive positioning and potential for recovery, including: - China Petroleum (601857 CH) with a target price of 9.79 and an "Overweight" rating [6]. - Hengli Petrochemical (600346 CH) with a target price of 17.55 and an "Overweight" rating [6]. - Juhua Co. (600160 CH) with a target price of 31.92 and a "Buy" rating [6]. - Other recommended companies include Dongyue Group, Luxi Chemical, Meihua Biological Technology, and Xinghuo Technology [6][32].

Investment Rating - The report assigns an "Outperform" rating to the company with a target price of RMB 9.09, representing a potential upside of 15% from the current price of RMB 7.64 [1][9]. Core Insights - The company's net profit attributable to shareholders for 2024 is projected to be RMB 943 million, a year-on-year increase of 39.12%, while the net profit after non-recurring items is expected to grow by 57.07% to RMB 1.14 billion [1][9]. - The revenue for 2024 is forecasted at RMB 17.33 billion, reflecting a slight decline of 0.23% year-on-year, primarily due to lower product prices [1][9]. - The company plans to distribute a cash dividend of RMB 0.38 per share, totaling approximately RMB 631.36 million, which accounts for 66.94% of the net profit attributable to shareholders [1][9]. Financial Summary - The company achieved a net profit of RMB 678 million in 2023, with projections of RMB 943 million for 2024, RMB 1.32 billion for 2025, RMB 1.43 billion for 2026, and RMB 1.60 billion for 2027 [3][9]. - The earnings per share (EPS) are expected to increase from RMB 0.41 in 2023 to RMB 0.57 in 2024, RMB 0.79 in 2025, RMB 0.86 in 2026, and RMB 0.96 in 2027 [3][9]. - The company's return on equity (ROE) is projected to rise from 9.0% in 2023 to 12.0% in 2024, reaching 15.0% by 2025 [3][9]. Major Projects - The company is accelerating the construction of a 600,000-ton corn deep processing and cogeneration project, aiming for trial production by the end of 2025, with a total investment of RMB 3.71 billion [10]. - Additionally, the company is making steady progress on the Zhaodong nucleotide project, with a self-funded investment of RMB 167.29 million for a 3,500-ton product upgrade over 16 months [10].

ZL200910266085.7 号专利（以下简称 085 号专利）的 5'-呈味核苷 酸二钠（"IMP 加 GMP"，也称 I+G）和 5'-肌苷酸二钠（"IMP"），并 销毁侵犯专利权的"IMP 加 GMP"和"IMP"（以下简称：核酸产品）； 证券代码：600866 证券简称：星湖科技 公告编号：临 2025-022 广东肇庆星湖生物科技股份有限公司 关于前期诉讼进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： 对上市公司损益的影响：终审判决驳回原告 CJ 第一制糖株式会社 的上诉，维持一审原判，即驳回原告 CJ 第一制糖株式会社的全部诉讼 请求。本次侵害发明专利权纠纷案终审判决已生效，不会对公司本期 利润或期后利润产生重大影响。 一、本次诉讼的基本情况 （一）原告 CJ 第一制糖株式会社认为广东肇庆星湖生物科技股 份有限公司（以下简称"公司"或"被告"）侵害其发明专利，于 2019 年 7 月 11 日向广州知识产权法院提起诉讼，请求如下： 1.判令被告立即停止生产、销售、许诺销售侵犯原告第 ...

Investment Rating - The report assigns an "Outperform" rating to the company with a target price of RMB 9.09, representing a potential upside of 15% from the current price of RMB 7.64 [1][9]. Core Insights - The company's net profit attributable to shareholders for 2024 is projected to be RMB 943 million, a year-on-year increase of 39.12%, while the net profit after non-recurring items is expected to grow by 57.07% to RMB 1.14 billion [1][9]. - The revenue for 2024 is forecasted at RMB 17.33 billion, a slight decline of 0.23% year-on-year, primarily due to lower product prices [1][9]. - The company plans to distribute a cash dividend of RMB 0.38 per share, totaling approximately RMB 631.36 million, which accounts for 66.94% of the net profit attributable to shareholders [1][9]. Financial Summary - The company achieved a net profit of RMB 678 million in 2023, with projections of RMB 943 million for 2024, RMB 1.32 billion for 2025, RMB 1.43 billion for 2026, and RMB 1.60 billion for 2027 [3][9]. - The earnings per share (EPS) are expected to increase from RMB 0.41 in 2023 to RMB 0.57 in 2024, RMB 0.79 in 2025, RMB 0.86 in 2026, and RMB 0.96 in 2027 [3][9]. - The company's return on equity (ROE) is projected to rise from 9.0% in 2023 to 15.0% in 2025, maintaining at 14.8% in the following years [3][9]. Major Projects - The company is advancing its 600,000-ton corn deep processing and cogeneration project, aiming for trial production by the end of 2025, with a total investment of RMB 3.71 billion [10]. - The project includes a processing line for producing 115,000 tons/year of various amino acids and related by-products [10]. - Additionally, the company is progressing with the Zhaodong nucleotide project, which involves a self-funded investment of RMB 167.29 million for a 3,500-ton product upgrade over 16 months [10].

Group 1 - The corn concept sector experienced a decline of 1.00%, ranking among the top declines in the concept sector, with leading decliners including Fengle Seed Industry, Jindan Technology, and Qianyuan High-Tech [1][2] - Among the stocks in the corn concept sector, six stocks saw price increases, with Guangyu Group, Fucheng Co., and Yantang Dairy leading the gains at 4.32%, 1.71%, and 0.92% respectively [1][2] - The corn concept sector saw a net outflow of 303 million yuan from main funds today, with 22 stocks experiencing net outflows, and 13 stocks seeing outflows exceeding 10 million yuan [2][3] Group 2 - The stock with the highest net outflow was Jinjian Rice Industry, with a net outflow of 48.06 million yuan, followed by Jindan Technology, Xinghu Technology, and Qianyuan High-Tech with net outflows of 34.74 million yuan, 29.16 million yuan, and 28.98 million yuan respectively [2][3] - The stocks with the highest net inflows included Guangyu Group, Yuntu Holdings, and Longping High-Tech, with net inflows of 10.64 million yuan, 8.37 million yuan, and 7.01 million yuan respectively [2][3] - The corn concept sector's performance was contrasted by other sectors, such as the Chengfei concept which rose by 7.01%, and the soybean sector which fell by 1.62% [2]